Sonus Pharmaceuticals, Inc.
22026 20th Avenue SE, Suite 102
Bothell
Washington
98021
United States
Tel: 425-487-9500
Fax: 425-489-0626
Website: http://www.sonuspharma.com/
Email: info@sonuspharma.com
50 articles about Sonus Pharmaceuticals, Inc.
-
OncoGenex Pharmaceuticals Inc. Lays-Off Half of Staff
8/22/2008
-
Sonus Pharmaceuticals, Inc. and OncoGenex Technologies Inc. Complete Business Combination
8/21/2008
-
Sonus Pharmaceuticals, Inc.'s Stockholders Approve Business Combination With OncoGenex Technologies Inc.
8/20/2008
-
Sonus Pharmaceuticals, Inc. Sets Date of Special Shareholders' Meeting
8/19/2008
-
Sonus Pharmaceuticals, Inc. Signs Exclusive In-Licensing Agreement With Bayer HealthCare AG for Caspase Activator Compounds
8/7/2008
-
Sonus Pharmaceuticals, Inc. Receives Favorable NASDAQ Decision
7/18/2008
-
Sonus Pharmaceuticals, Inc. and OncoGenex Technologies Inc. to Merge
5/28/2008
-
Sonus Pharmaceuticals, Inc. Receives Staff Determination Letter From Nasdaq
5/9/2008
-
Sonus Pharmaceuticals, Inc. Ends Discovery Efforts of Two Programs and Reduces its Headcount
3/25/2008
-
Sonus Pharmaceuticals, Inc. Reports Fourth Quarter and Year End Financial Results
3/6/2008
-
Sonus Pharmaceuticals, Inc. Reports Third Quarter Financial Results
11/13/2007
-
Sonus Pharmaceuticals, Inc. to Release Third Quarter Financial Results and Hold Quarterly Conference Call on November 12
10/30/2007
-
Sonus Pharmaceuticals, Inc. Engages Ferghana Partners Inc. as Strategic Advisor
10/23/2007
-
Sonus Pharmaceuticals, Inc. to Hold Conference Call to Discuss Results from Pivotal Phase 3 Trial of TOCOSOL(R) Paclitaxel
9/24/2007
-
Sonus Pharmaceuticals, Inc. Phase 3 Pivotal Trial of TOCOSOL(R) Paclitaxel Does Not Meet Primary Endpoint
9/24/2007
-
Biotech Sonus Pharmaceuticals, Inc. Could Soar on Drug Results
8/28/2007
-
Sonus Pharmaceuticals, Inc. Highlights Corporate Progress and Reports Second Quarter Financial Results
8/3/2007
-
Sonus Pharmaceuticals, Inc. to Release Second Quarter Financial Results and Hold Quarterly Conference Call on August 3
7/20/2007
-
Sonus Pharmaceuticals, Inc. Awarded Patent for TOCOSOL(R) Camptothecin, the Company's Second Oncology Product Candidate
6/13/2007
-
Sonus Pharmaceuticals, Inc. Highlights Progress and Reports First Quarter Financial Results
5/10/2007